CHRISTINA MILLER: Open Payments
NPI 1023789328 · DERIDDER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 21 payments from 15 companies in 2025. Trend: 2023 $64 · 2024 $483 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $62 |
| ABBVIE INC. | 3 | $42 |
| Lilly USA, LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| BioMarin Pharmaceutical Inc. | 1 | $35 |
| Ardelyx, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
Products named: DUPIXENT, VOXZOGO 1.2mg, IBSRELA, ZEPBOUND, REXULTI, AIRSUPRA, Auvelity, UZEDY.
Industry payments across LA — which companies pay providers there.
